Jinping Lai
Kaiser Permanente Sacramento Medical Center · 185 works · 4,207 citations · h-index 30
Top works
- Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage
- Loss of HSulf-1 Up-regulates Heparin-binding Growth Factor Signaling in Cancer
- Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
- Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
- Familial Adenomatous Polyposis Syndrome: An Update and Review of Extraintestinal Manifestations
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma†
- Solid Pseudopapillary Neoplasm of the Pancreas: A Rare Entity With Unique Features
- Parkin gene alterations in hepatocellular carcinoma
- In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis
- Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
- Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes
- Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus
- Clinicopathologic features of Buschke-Löwenstein tumor: a multi-institutional analysis of 38 cases
- Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children
- SULF1 Inhibits Tumor Growth and Potentiates the Effects of Histone Deacetylase Inhibitors in Hepatocellular Carcinoma
- Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice
- New scoring classification for primary biliary cholangitis–autoimmune hepatitis overlap syndrome
- Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis
- Histologic patterns of liver injury induced by anti-PD-1 therapy